HAG
HighPoint Advisor Group’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.41M | Buy |
3,632
+278
| +8% | +$108K | 0.08% | 200 |
|
2025
Q1 | $1.39M | Buy |
3,354
+162
| +5% | +$67K | 0.08% | 198 |
|
2024
Q4 | $1.25M | Sell |
3,192
-277
| -8% | -$108K | 0.07% | 213 |
|
2024
Q3 | $1.44M | Buy |
3,469
+26
| +0.8% | +$10.8K | 0.08% | 189 |
|
2024
Q2 | $1.85M | Buy |
3,443
+50
| +1% | +$26.8K | 0.11% | 149 |
|
2024
Q1 | $1.83M | Buy |
3,393
+255
| +8% | +$137K | 0.13% | 133 |
|
2023
Q4 | $1.6M | Buy |
+3,138
| New | +$1.6M | 0.11% | 143 |
|
2022
Q2 | $1.72M | Buy |
+3,558
| New | +$1.72M | 0.19% | 100 |
|
2021
Q3 | $842K | Sell |
2,258
-123
| -5% | -$45.9K | 0.08% | 206 |
|
2021
Q2 | $909K | Buy |
2,381
+270
| +13% | +$103K | 0.09% | 186 |
|
2021
Q1 | $762K | Sell |
2,111
-75
| -3% | -$27.1K | 0.09% | 185 |
|
2020
Q4 | $653K | Buy |
2,186
+585
| +37% | +$175K | 0.08% | 202 |
|
2020
Q3 | $512K | Buy |
1,601
+135
| +9% | +$43.2K | 0.09% | 180 |
|
2020
Q2 | $394K | Buy |
1,466
+42
| +3% | +$11.3K | 0.08% | 196 |
|
2020
Q1 | $376K | Sell |
1,424
-110
| -7% | -$29K | 0.09% | 185 |
|
2019
Q4 | $469K | Buy |
1,534
+166
| +12% | +$50.8K | 0.1% | 187 |
|
2019
Q3 | $385K | Buy |
1,368
+409
| +43% | +$115K | 0.09% | 199 |
|
2019
Q2 | $289K | Buy |
+959
| New | +$289K | 0.07% | 252 |
|
2019
Q1 | – | Sell |
-3,136
| Closed | -$977K | – | 345 |
|
2018
Q4 | $977K | Sell |
3,136
-332
| -10% | -$103K | 0.26% | 90 |
|
2018
Q3 | $956K | Sell |
3,468
-466
| -12% | -$128K | 0.26% | 91 |
|
2018
Q2 | $1.05M | Buy |
3,934
+368
| +10% | +$98.1K | 0.28% | 93 |
|
2018
Q1 | $814K | Sell |
3,566
-46
| -1% | -$10.5K | 0.22% | 120 |
|
2017
Q4 | $843K | Sell |
3,612
-805
| -18% | -$188K | 0.24% | 107 |
|
2017
Q3 | $930K | Sell |
4,417
-226
| -5% | -$47.6K | 0.29% | 89 |
|
2017
Q2 | $884K | Hold |
4,643
| – | – | 0.28% | 83 |
|
2017
Q1 | $884K | Sell |
4,643
-946
| -17% | -$180K | 0.28% | 83 |
|
2016
Q4 | $933K | Buy |
+5,589
| New | +$933K | 0.3% | 80 |
|